Risks and Benefits Sample Clauses

Risks and Benefits. Our study involves individual, confidential interviews about your lived experiences in the workplace, but due to the sensitive and personal nature of the interview process, participants might have feelings of anxiety or stress recounting personal, emotional or traumatic experiences in the past. To mitigate this psychological risk to participation, the research team has a protocol for dealing with stressful situations. If during the interview you feel severe emotional stress, the research team will offer moral support and options to mitigate the stress such as allowing participants to pause, take a break, or exit the interview if required. ▇▇. ▇▇▇▇▇▇ has a physical disability and can empathize with the interviewee. Before commencing, the researchers will remind you that you may decline to answer any questions or discontinue the interview at any time without fear of penalty. There are some limits to confidentiality associated with individuals’ roles, expertise, locations or disabilities where our reporting research results could result in a person being identified —e.g., if there might only be a relatively small number of individuals with the roles, expertise, locations or disabilities in question. We will do our best to mask individual identity by using general descriptions about your place of work and geographic location. We would like to document your work space with photos (if possible). This is not a requirement for your participation, however. Any photos of work spaces or accommodations will only be used by the researchers for analysis and not shared with people outside our research team. For any external reporting on the research, such as in journal articles, our website, or conference presentations, we will discuss participants’ accommodations textually or use stock digital images. We are interested in having photos because understanding the physical workspace needs of workers with disabilities may contribute to a better understanding among employers and policy makers about what works best. The researchers intend to share the research results with participants, employers, policy makers, funders, governments and the public. The research outcomes could contribute to better working conditions for people with physical disabilities, improved hiring practices for employers, a more positive and inclusive labour environment for people living with disabilities who want to be employed, and improved public understanding of people living with disabilities, their...

Risks and Benefits. This paragraph describes the Parties’ understandings of important risks and benefits relevant to this Agreement; it is not intended as a‌ comprehensive statement of all such risks and benefits. As set forth in Paragraph 2 above, litigation over the SAFE Rule Part One and the SAFE Rule Part Two, as well as potential further federal regulatory actions, create uncertainty for BMW NA regarding the GHG standards that will apply throughout the United States for Model Year 2021 through Model Year 2026 and subsequent. The outcome of this litigation or additional federal regulatory actions may result in two GHG compliance standards in the United States for the covered Model Years: requirements to comply with more stringent CA Standards in California and the Section 177 States; and less stringent SAFE Rule Part Two standards throughout the rest of the United States. This regulatory uncertainty also subjects BMW NA to considerable enforcement risk. Therefore, BMW NA enters into this agreement to ensure, among other reasons, that it has the ability to (i) make long-term product planning decisions and investments with confidence; (ii) satisfy market demand and production realities; and (iii) comply with regulatory requirements during this time. This Settlement Agreement offers BMW NA compliance flexibility and greater certainty to plan for its nationwide fleet. The SAFE Rule Part One and SAFE Rule Part Two, and the related litigation, also entail risks that California and the Section 177 States may not achieve the pollutant reduction goals they expected to result from the CA Standards. Entry into this Settlement Agreement is consistent with those goals, including goals set out in the AB 32 Scoping Plan, and will deliver environmental benefits commensurate with those goals that may not be realized in the absence of an agreement. Each Section 177 State has made consistent judgments, reflected in the Enforcement Discretion Letters.

Risks and Benefits. Contact lenses may offer improved peripheral vision and the convenience of not wearing spectacles. Material properties and design characteristics of the contact lens in development are features consistent with successful contact lens wear. PRECISION1 and Clariti 1-Day contact lenses are for daily wear use under a daily disposable wear modality; further details on any known potential risks and benefits can be found in the package insert. PRECISION1 and Clariti 1-Day contact lenses are not intended for use with a cleaning/disinfecting solution, and the biocompatibility with lens care solutions and any associated clinical effects are unknown. A summary of the known potential risks and benefits associated with PRECISION1 can be found in the package insert. Risks are minimized by compliance with the eligibility criteria and study procedures, and through close supervision by a licensed clinician during exposure to the study lenses. The site personnel will educate subjects on proper hygiene and lens handling, and compliance with the use of contact lenses according to the protocol. Subjects should be instructed not to wear contact lenses while sleeping or swimming. The site personnel will also advise the subjects to remove contact lenses and return for prompt follow-up of symptoms, such as ocular discomfort, foreign body sensation, excessive tearing, vision changes, or hyperemia. There may also be unknown risks to use of these study contact lenses. Any risk to subjects in this clinical study will be minimized by compliance with the eligibility criteria and study procedures, clinical oversight and monitoring.

Risks and Benefits. I further understand that the initial symptoms or problems presented may initially become more intense because confronting important questions about who I am and who I want to be may at times cause internal conflict. I understand the psychotherapy requires an active investment of various resources (emotional, time, financial, and others) that may lead to uncomfortable feelings like sadness, anger, or frustration. On the other hand, I understand psychotherapy has also been shown to have many benefits. Psychotherapy often leads to better relationships, solutions to specific problems, and significant reductions in feelings of distress. I understand there are no guarantees of what I as an individual and/or my family or minor child will achieve as outcomes.

Risks and Benefits. Contact lenses may offer improved peripheral vision and the convenience of not wearing spectacles. Biofinity contact lenses are approved for extended wear for up to 6 nights/7 days of continuous wear. Further details on any known potential risks and benefits can be found in the package insert. Material properties and design characteristics of the investigational (not approved by the FDA) contact lenses are consistent with successful contact lens wear. To date, supportive results from preclinical tests and documented rationale for applicability of test results, and the previous clinical studies, described in the IB, provide a basis for the anticipated acceptable performance and safety profile of the contact lenses for up to 6 continuous nights of extended wear with planned weekly replacement in the upcoming 12-month registration study. This study will evaluate any long term or new risks with the extended wear of contact lenses and how these risks compare to a marketed extended wear control lens. A summary of the known and potential risks and benefits associated with contact lenses is presented in the IB. The potential ▇▇▇▇▇ associated with on-eye exposure to the new lens materials include toxicity response, blurred vision, and ocular discomfort. Under the conditions of a clinical study, which include compliance with subject selection criteria, oversight by study Investigators, adequate informed consent, subject instructions, scheduled lens wear/replacement, and frequent follow-up visits, risks to study subjects are controlled and minimized. Site personnel will educate subjects on proper hygiene and lens handling, and compliance with the use of contact lenses according to the protocol. Subjects should be instructed not to wear contact lenses while swimming due to increased risk of infection. Site personnel should advise the subjects to remove contact lenses and return for prompt follow-up of symptoms such as ocular discomfort, foreign body sensation, excessive tearing, vision changes, or hyperemia. Refer to the IB for additional information.

Risks and Benefits. This paragraph describes the Parties’ understandings of important risks and benefits relevant to this Agreement; it is not intended as a comprehensive statement of all such risks and benefits. As set forth in Paragraph 2 above, litigation over the SAFE Rule Part One and the SAFE Rule Part Two, as well as potential further federal regulatory actions, create uncertainty for Ford regarding the GHG standards that will apply throughout the United States for Model Year 2021 through Model Year 2026 and subsequent. The outcome of this litigation or additional federal regulatory actions may result in two GHG compliance standards in the United States for the covered Model Years: requirements to comply with more stringent CA Standards in California and the Section 177 States; and less stringent SAFE Rule Part Two standards throughout the rest of the United States. This regulatory uncertainty also subjects Ford to considerable‌ enforcement risk. Therefore, Ford enters into this agreement to ensure, among other reasons, that it has the ability to (i) make long-term product planning decisions and investments with confidence; (ii) satisfy market demand and production realities; and

Risks and Benefits. What are the risks to the individual(s) and how will you mitigate these? Provide a list of risks and how you will manage these. For example, how will you limit the exposure of a data subject and limit the invasion into privacy? What are the benefits to the subjects? Are there any risks for the council?

Risks and Benefits. I understand that there may be potential risks associated with extended VR usage, and there may be benefits in terms of improving well-being and understanding the technology better.

Risks and Benefits. Our study involves individual, confidential interviews about your lived experiences in the workplace, but due to the sensitive and personal nature of the interview process, participants might have feelings of anxiety or stress recounting personal, emotional or traumatic experiences in the past. To mitigate this psychological risk to participation, the research team has a protocol for dealing with stressful situations. If during the interview you feel severe emotional stress, the research team will offer moral support and options to mitigate the stress such as allowing participants to pause, take a break, or exit the interview if required. ▇▇. ▇▇▇▇▇▇ has a physical disability and can empathize with the interviewee. Before commencing, the researchers will remind you that you may decline to answer any questions or discontinue the interview at any time without fear of penalty. There are some limits to confidentiality associated with individuals’ roles, expertise, locations or disabilities where our reporting research results could result in a person being identified —e.g., if there might only be a relatively small number of individuals with the roles, expertise, locations or disabilities in question. We will do our best to mask individual identity by using general descriptions about your place of work and geographic location. The researchers intend to share the research results with participants, employers, policy makers, funders, governments and the public. The research outcomes could contribute to better working conditions for people with physical disabilities, improved hiring practices for employers, a more positive and inclusive labour environment for disabled people who want to be employed, and improved public understanding of disabled people, their challenges and needs. This potential benefit is the primary motivation for carrying out the study, and the researchers are transparent about pursuing actionable research outcomes (if some might consider this a bias). In the unlikely event that the researchers are asked to divulge their sources or breach confidentiality, they will refuse to do so and seek legal counsel. There are no other known physical, social or legal risks to participating in this project.